5-Amino-1MQ is a first-in-class small molecule inhibitor designed to target Nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that acts as a master regulator of the cellular "metabolic drain."
Partner with a professional for safety and results : Because 5-Amino-1MQ is a research compound and not FDA-approved, working with a medical provider is essential
Prioritize stress management techniques and regular physical activity during daytime hours
Start: Begin at 2.5 mg once daily for the first 12 days to gauge tolerability
Here are some common scenarios: Initial Treatment Phase: In the initial phase of treatment, injections may be administered more frequently, such as daily or weekly, until B12 levels are restored
For severe deficiencies, especially those with neurological symptoms, a full resolution of symptoms might take several weeks or even months of consistent treatment